-
Fetal heart rate in chromosomally abnormal fetuses.
Liao A W, Snijders R, Geerts L, Spencer K, Nicolaides KH.
Ultrasound Obstet Gynecol 2000;16:610-3. -
Hyaluronan in the nuchal skin of chromosomally abnormal fetuses.
Bohlandt S, von Kaisenberg CS, Wewetzer K, Christ B, Nicolaides KH, Brand-Saberi B.
Hum Reprod 2000;15:1155-8. -
Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses.
von Kaisenberg CS, Brand-Saberi B, Jonat W, Nicolaides KH.
Der Gynäkologe 1999;32:193-199. -
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:231-7. -
Nuchal translucency as a marker of congenital heart disease.
Perdu M, Hyett JA, Sharland G, Snijders RS, Nicolaides KH.
Contracept Fertil Sex 1999;27:I-V. -
Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks.
Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;14:307-10. -
Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH.
BMJ 1999;318:81-5. -
International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used.
Evans MI, Henry GP, Miller WA, Bui TH, Snidjers RJ, Wapner RJ, Miny P, Johnson MP, Peakman D, Johnson A, Nicolaides K, Holzgreve W, Ebrahim SA, Babu R, Jackson L.
Hum Reprod 1999;14:1213-6. -
First trimester umbilical venous Doppler sonography in chromosomally normal and abnormal fetuses.
Brown RN, Di Luzio L, Gomes C, Nicolaides KH.
J Ultrasound Med 1999;18:543-6. -
Investigation of maternal blood enriched for fetal cells: role in screening and diagnosis of fetal trisomies.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
Am J Med Genet 1999;2;85:66-75. -
Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse.
von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B.
Anat Embryol 1998;197:105-24. -
Detection of sex chromosome abnormalities by nuchal translucency screening at 10-14 weeks.
Sebire NJ, Snijders RJ, Brown R, Southall T, Nicolaides KH.
Prenat Diagn 1998;18:581-4. -
Screening for fetal abnormalities in multiple pregnancies.
Sebire NJ, Nicolaides KH.
Baillieres Clin Obstet Gynaecol 1998;12:19-36. -
Correct estimation of parameters for ultrasound nuchal translucency screening.
Nicolaides KH, Snijders RJ, Cuckle HS.
Prenat Diagn 1998;18:519-23. -
Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow.
Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;12:380-4. -
The umbilical artery pulsatility index in the first trimester: is there an association with increased nuchal translucency or chromosomal abnormality?
Brown R, Di Luzio L, Gomes C, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;12:244-7. -
Crown-chin length in normal and anencephalic fetuses at 10-14 weeks gestation.
Sepulveda W, Sebire NJ, Fung TY, Pipi E, Nicolaides KH.
Am J Obstet Gynecol 1997;176:852-5. -
Fetal nuchal translucency thickness at 10-14 weeks gestation and congenital diaphragmatic hernia.
Sebire NJ, Snijders RJ, Davenport M, Greenough A, Nicolaides KH.
Obstet Gynecol 1997;90:943-6. -
Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10-14 weeks of gestation.
Sebire NJ, Spencer K, Noble PL, Hughes K, Nicolaides KH.
BJOG 1997;104:849-51. -
Management of twin pregnancies with fetal trisomies.
Sebire NJ, Snijders RJM, Santiago C, Papapanagiotou G, Nicolaides KH.
BJOG 1997;104:220-2.